The formulations were assessed on assay, dissolution, friability, weight variation and disintegration time.
Anti-nociceptive efficacy of the formulations was assessed on Wistar rats by hot plate and tail flick tests, based on the response to pain perception.
The formulation is assessed on real-life instances.
The proposed formulation has been assessed on both simulated and real sEMG data.
Effect of formulation and process variants was assessed on uniformity and fineness of fibrous scaffolds.
The lipid structure of PSME and location of BCH in the formulation were assessed based on experimental results.
Appropriate kinetic formulations were assessed.
The difference in Tmax values between the two formulations was assessed using nonparametric Wilcoxon signed rank test using SAS Enterprise guide 5.1.
New vaccine formulations were assessed for their ability to induce improved CS-specific immune responses.
The proposed formulation is assessed by means of a parametric study based on the comparison with numerical results retrieved from finite element simulations, in order to assess the range of validity of each expression.
